1.Alternative Name:MCP；AHUS2; CD46 antigen; CD46 molecule, complement regulatory protein; CD46; MCP; membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen); MIC10; TLXcomplement regulatory protein; trophoblast leucocyte common antigen; Trophoblast leukocyte common antigen; trophoblast-lymphocyte cross-reactive antigen
2.Target:CD46
3.Source:Human CD46 was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Cys35-Asp343
5.Protein structure:P15529hFC
6.Molecular Characterization:The protein has a calculated MW of 60kDa.The reducing (R) heterodimer protein migrates as 70-100 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 90%.

    

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

    

13.ELISA

When Recombinant Human CD46/hFC Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human CD46 that produces 50% of the optimal binding response is approximately 0.3 ug/ml.